Furthermore, the expression levels of several genes (PLOD3, SLC20A1, ADAM9, FBLIM1, SPOCD1, P4HB, PROS1 and SELENON) were positively correlated with glioma grades (Figure 4D and Figure S6B). This evidence concerns the gene SLC20A1 and central nervous system cancer.